JP2014534227A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014534227A5 JP2014534227A5 JP2014540047A JP2014540047A JP2014534227A5 JP 2014534227 A5 JP2014534227 A5 JP 2014534227A5 JP 2014540047 A JP2014540047 A JP 2014540047A JP 2014540047 A JP2014540047 A JP 2014540047A JP 2014534227 A5 JP2014534227 A5 JP 2014534227A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- moiety
- compound according
- linker
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161553854P | 2011-10-31 | 2011-10-31 | |
| US61/553,854 | 2011-10-31 | ||
| PCT/US2012/062850 WO2013151584A1 (en) | 2011-10-31 | 2012-10-31 | Compound comprising a mao targeting/ seeker moiety for treating human gliomas |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014534227A JP2014534227A (ja) | 2014-12-18 |
| JP2014534227A5 true JP2014534227A5 (OSRAM) | 2015-11-12 |
| JP6118808B2 JP6118808B2 (ja) | 2017-04-19 |
Family
ID=47146760
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014540047A Expired - Fee Related JP6118808B2 (ja) | 2011-10-31 | 2012-10-31 | ヒトグリオームを治療するためのｍａｏ標的化／探索部分を含む化合物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US10555936B2 (OSRAM) |
| EP (2) | EP2804604A1 (OSRAM) |
| JP (1) | JP6118808B2 (OSRAM) |
| KR (1) | KR102110794B1 (OSRAM) |
| CN (1) | CN104136026B (OSRAM) |
| AU (1) | AU2012376221A1 (OSRAM) |
| CA (1) | CA2887928A1 (OSRAM) |
| HK (1) | HK1204547A1 (OSRAM) |
| WO (1) | WO2013151584A1 (OSRAM) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HK1204547A1 (en) | 2011-10-31 | 2015-11-27 | The Methodist Hospital | Compound comprising a mao targeting/ seeker moiety for treating human gliomas |
| CN104710433B (zh) * | 2014-01-23 | 2016-08-17 | 南京友怡医药科技有限公司 | 苯丁酸氮芥衍生物、制备方法及应用 |
| US10807944B2 (en) * | 2014-04-04 | 2020-10-20 | University Of Florida Research Foundation, Inc. | HDAC inhibitor compounds and methods of treatment |
| JP2024511277A (ja) | 2021-02-19 | 2024-03-13 | メビオン・メディカル・システムズ・インコーポレーテッド | 粒子線治療システムのためのガントリー |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4913891A (en) * | 1986-04-17 | 1990-04-03 | The United States Of America As Represented By The United States Department Of Energy | Positron emitter labeled enzyme inhibitors |
| US5466468A (en) | 1990-04-03 | 1995-11-14 | Ciba-Geigy Corporation | Parenterally administrable liposome formulation comprising synthetic lipids |
| US5399363A (en) | 1991-01-25 | 1995-03-21 | Eastman Kodak Company | Surface modified anticancer nanoparticles |
| CA2164518A1 (en) * | 1993-06-07 | 1994-12-22 | Cristopher D.V. Black | Immunoreactive reagents employing monoamine oxidase |
| US5543158A (en) | 1993-07-23 | 1996-08-06 | Massachusetts Institute Of Technology | Biodegradable injectable nanoparticles |
| IE80468B1 (en) | 1995-04-04 | 1998-07-29 | Elan Corp Plc | Controlled release biodegradable nanoparticles containing insulin |
| US5612329A (en) | 1995-06-05 | 1997-03-18 | University Of Maryland At Baltimore | Diaziridinylpolyamine anti-cancer agents |
| WO1998022110A1 (en) * | 1996-11-20 | 1998-05-28 | Virginia Tech Intellectual Properties, Inc. | Prodrugs for the selective inhibition of monoamine oxidase-b |
| IL145089A0 (en) | 1999-03-03 | 2002-06-30 | Procter & Gamble | Alkenyl-and alkynyl-containing metalloprotease inhibitors |
| US6750345B2 (en) | 2000-11-07 | 2004-06-15 | Symyx Technologies, Inc. | Substituted pyridyl amine catalysts, complexes and compositions |
| US6946479B2 (en) | 2002-11-09 | 2005-09-20 | The Procter & Gamble Company | N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones |
| WO2004110255A2 (en) | 2003-06-09 | 2004-12-23 | Gang Zheng | Antineoplastic agents targeted via glut transporters |
| EP1758887A1 (en) * | 2004-05-14 | 2007-03-07 | Pfizer Products Incorporated | Pyrimidine derivatives for the treatment of abnormal cell growth |
| US7091205B2 (en) | 2004-10-08 | 2006-08-15 | Yu Show Fu | Use of tetramethylpyrazine in the treatment of brain tumor |
| GB0513297D0 (en) | 2005-06-29 | 2005-08-03 | Glaxo Group Ltd | Novel compounds |
| US20070275944A1 (en) | 2006-04-05 | 2007-11-29 | The Board Of Trustees Operating Michigan State University | Antioxidants and methods of their use |
| AR070317A1 (es) * | 2008-02-06 | 2010-03-31 | Osi Pharm Inc | Furo (3,2-c) piridina y tieno (3,2-c) piridinas |
| WO2009111278A2 (en) * | 2008-02-29 | 2009-09-11 | Array Biopharma Inc. | Raf inhibitor compounds and methods of use thereof |
| EP2141163A1 (de) * | 2008-07-02 | 2010-01-06 | Bayer Schering Pharma AG | Substituierte Thiazolidinone, deren Herstellung und Verwendung als Arzneimittel |
| EP3613729A1 (en) * | 2009-06-10 | 2020-02-26 | Chugai Seiyaku Kabushiki Kaisha | Tetracyclic compounds |
| WO2011035332A1 (en) * | 2009-09-21 | 2011-03-24 | Chemocentryx, Inc. | Pyrrolidinone carboxamide derivatives as chemerin-r ( chemr23 ) modulators |
| HK1204547A1 (en) | 2011-10-31 | 2015-11-27 | The Methodist Hospital | Compound comprising a mao targeting/ seeker moiety for treating human gliomas |
-
2012
- 2012-10-31 HK HK15103179.0A patent/HK1204547A1/xx unknown
- 2012-10-31 EP EP12783818.3A patent/EP2804604A1/en not_active Withdrawn
- 2012-10-31 EP EP20189611.5A patent/EP3815685A3/en not_active Withdrawn
- 2012-10-31 KR KR1020147014835A patent/KR102110794B1/ko active Active
- 2012-10-31 CN CN201280064763.1A patent/CN104136026B/zh not_active Expired - Fee Related
- 2012-10-31 AU AU2012376221A patent/AU2012376221A1/en not_active Abandoned
- 2012-10-31 WO PCT/US2012/062850 patent/WO2013151584A1/en not_active Ceased
- 2012-10-31 JP JP2014540047A patent/JP6118808B2/ja not_active Expired - Fee Related
- 2012-10-31 CA CA2887928A patent/CA2887928A1/en not_active Abandoned
-
2014
- 2014-04-30 US US14/266,729 patent/US10555936B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102123365B1 (ko) | 항박테리아 치료제 및 예방제 | |
| JP6352244B2 (ja) | 骨格筋疲労に対する耐性を向上させるための方法 | |
| US20170157168A1 (en) | Prevention of gastric ulcer by carbon monoxide | |
| JP2011529474A (ja) | ｃｄｋ阻害剤および抗悪性腫瘍剤を含む治療用組合せ | |
| JP2010523696A (ja) | 脳腫瘍を治療する方法 | |
| TW201244714A (en) | PARP inhibitors for the treatment of CIPN | |
| WO2008131024A1 (en) | Iodo-hexose compounds useful to treat cancer | |
| US20200179417A1 (en) | Combination chemotherapies | |
| JP2014534227A5 (OSRAM) | ||
| US11224608B2 (en) | Compounds and methods for treating cancer | |
| RU2011151861A (ru) | Оксазолидинонсодержащие димерные соединения, композиции и способы их получения и использования | |
| JP2013504590A (ja) | 非放射性リン脂質化合物、組成物、及び使用方法 | |
| EP3011972A1 (en) | Medicinal composition for promoting synthesis of protoporphyrin ix | |
| TW201309298A (zh) | 治療惡性神經膠質瘤之醫藥組合物 | |
| Friedman et al. | Schedule-dependent activity of irinotecan plus BCNU against malignant glioma xenografts | |
| JP2019523783A (ja) | がんの治療に有用なポルフィリン化合物及び組成物 | |
| US10774063B2 (en) | Materials and method for inhibiting replication protein A and uses thereof | |
| CN104136026B (zh) | 包含mao靶向/探寻器部分的人神经胶质瘤治疗用化合物 | |
| AU2017235350B2 (en) | Combination therapy for proliferative diseases | |
| WO2018222134A1 (en) | Cancer therapy | |
| CA3115103A1 (en) | Pi3k inhibitors and uses thereof | |
| US20100087398A1 (en) | Dihydropyridine derivative for treating cancer or a pre-cancerous condition and other conditions | |
| RU2639819C2 (ru) | Композиция, ингибирующая теломеразу | |
| KR20230147351A (ko) | 퀴녹살린 카르복스아마이드 유도체 및 이를 유효성분으로 포함하는 교모세포종의 예방 또는 치료용 약학적 조성물 | |
| CN118119611A (zh) | 用于降解dot1l的小分子及其用途 |